BIOFRONTERA AG (B8FK.DE) Stock Income Statement
FRA:B8FK - Deutsche Boerse Ag - DE000A4BGGM7 - Common Stock - Currency: EUR
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 23.72M | 21.67M | 32.25M | 25.74M | 28.79M | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | 4.46M | |||
| Cost Of Goods | 5.64M | 5.33M | 6.24M | 4.76M | 3.91M | |||
| Gross Profit | 18.08M | 16.34M | 26.01M | 20.98M | 24.87M | |||
| Operating Expenses | 21.19M | 21.86M | 20.92M | 19.48M | 39.69M | |||
| Research and Development | 4.48M | 5.17M | 7.68M | 6.97M | 6.95M | |||
| Selling, General, and Administrative Expenses | 17.12M | 16.45M | 12.91M | 11.80M | 30.65M | |||
| Operating Income | -3.12M | -5.52M | 5.09M | 1.50M | -14.81M | |||
| Interest Income/Expense | -95.00K | -1.20M | -7.22M | -44.71M | 11.18M | |||
| Other Income/Expense | N/A | -1.00K | -1.00K | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | 39.32M | |||
| Income Before Taxes | -3.33M | -6.72M | -2.13M | -43.21M | 35.68M | |||
| Income Tax | N/A | -2.37M | -1.76M | 956.00K | 1.83M | |||
| Net Income | -965.00K | -4.35M | -369.00K | -44.17M | 38.32M | |||
| EBITDA | N/A | -4.68M | 5.88M | 2.25M | -11.53M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.12 | -0.72 | -0.07 | -9.37 | 7.88 | |||
| Statistics | ||||||||
| Gross Profit Margin | 76.21% | 75.41% | 80.64% | 81.52% | 86.41% | |||
| Profit Margin | -4.07% | -20.08% | -1.14% | -171.60% | 133.11% | |||
| Operating Profit Margin | -13.13% | -25.48% | 15.78% | 5.84% | -51.46% | |||
All data in EUR